Alma Therapeutics focuses on advancing oral biologics delivery through innovative technologies designed to enhance the bioavailability and efficacy of therapeutic agents. Their proprietary platform utilizes a unique formulation approach that enables the effective transport of biologics across the gastrointestinal barrier. This technology aims to overcome the challenges typically associated with oral delivery of large molecules, such as proteins and peptides, which often face degradation in the digestive system.

The company’s pipeline includes a range of products that leverage this advanced delivery system, targeting various therapeutic areas. By optimizing the absorption and stability of biologics, Alma Therapeutics aims to provide more effective treatment options that can be administered orally, improving patient compliance and overall treatment outcomes. Their commitment to scientific research and development underpins their efforts to revolutionize the way biologics are delivered, making them more accessible and effective for patients.

Israel

Alma Therapeutics is developing a novel drug delivery platform for the oral delivery of complex molecules and biologics such as:
Peptides, Proteins and Antibodies

Alma Therapeutics

Company Details